|
Oxygenta Pharmaceutical Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
222.46 Cr.
|
P/BV
|
-11.33
|
Book Value (Rs.)
|
-5.31
|
|
52 Week High/Low (Rs.)
|
134/54
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2019
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 109.30 | 39.64 | 30.99 | 60.52 | 52.03 |
| Total Operating Revenues | 109.30 | 39.64 | 30.99 | 60.52 | 52.03 |
| | | | | | |
| Other Income | 1.31 | 0.04 | 0.02 | 0.00 | 0.09 |
| Total Revenue | 110.61 | 39.68 | 31.01 | 60.53 | 52.12 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 100.23 | 35.06 | 28.13 | 42.67 | 43.02 |
| Operating And Direct Expenses | 11.16 | 7.44 | 11.73 | 5.45 | 5.67 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -3.76 | -1.53 | -4.63 | 4.55 | -6.39 |
| Employee Benefit Expenses | 6.90 | 5.99 | 1.24 | 4.60 | 4.21 |
| Finance Costs | 1.78 | 1.59 | 1.49 | 0.92 | 1.78 |
| Depreciation And Amortisation Expenses | 0.82 | 2.66 | 2.05 | 1.59 | 1.20 |
| Other Expenses | 4.76 | 2.38 | 1.65 | 1.78 | 1.68 |
| Total Expenses | 121.89 | 53.59 | 41.64 | 61.57 | 51.16 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -11.28 | -13.91 | -10.64 | -1.04 | 0.95 |
| | | | | | |
| Exceptional Items | -0.27 | 0.04 | -0.73 | 0.55 | 2.19 |
| Profit/Loss Before Tax | -11.55 | -13.87 | -11.37 | -0.49 | 3.14 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Deferred Tax | -2.03 | -10.39 | 0.20 | 0.12 | 0.21 |
| Tax For Earlier Years | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Tax Expenses | -1.87 | -10.39 | 0.20 | 0.12 | 0.21 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -9.68 | -3.48 | -11.57 | -0.61 | 2.93 |
| | | | | | |
| Profit/Loss From Continuing Operations | -9.68 | -3.48 | -11.57 | -0.61 | 2.93 |
| | | | | | |
| Profit/Loss For The Period | -9.68 | -3.48 | -11.57 | -0.61 | 2.93 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | -2.69 | -1.09 | -8.15 | -0.48 | 2.87 |
| Diluted EPS (Rs.) | -2.69 | -1.04 | -8.15 | -0.48 | 2.87 |
